Anderegg, N. Panayidou, K. Abo, Y. Alejos, B. Althoff, K.N. Anastos, K. Antinori, A. Balestre, E. Becquet, R. Castagna, A. Castelnuovo, B. Chêne, G. Coelho, L. Collins, I.J. Costagliola, D. Crabtree-Ramírez, B. Dabis, F. D’Arminio Monforte, A. Davies, M.-A. De Wit, S. Delpech, V. De La Mata, N.L. Duda, S. Freeman, A. Gange, S.J. Grabmeier-Pfistershammer, K. Gunsenheimer-Bartmeyer, B. Jiamsakul, A. Kitahata, M.M. Law, M. Manzardo, C. McGowan, C. Meyer, L. Moore, R. Mussini, C. Nakigoz, G. Nash, D. Ng, O.T. Obel, N. Pantazis, N. Poda, A. Raben, D. Reiss, P. Riggen, L. Sabin, C. D’Amour Sinayobye, J. Sönnerborg, A. Stoeckle, M. Thorne, C. Torti, C. Twizere, C. Wasmuth, J.-C. Wittkop, L. Wools-Kaloustian, K. Yotebieng, M. Kirk, O. Egger, M. The IeDEA COHERE Cohort Collaborations, Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs, Clinical Infectious Diseases, (66), 893-903, 2018, Oxford University Press, 1058-4838, 1537-6591